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a b s t r a c t
Gingivitis and periodontitis are immunoinflammatory periodontal diseases characterized by 
chronic localized infections usually associated with insidious inflammation. This narrative 
review discusses periodontal diseases and mechanisms influencing the immune response 
and autoimmunity in pediatric rheumatic diseases (PRD), particularly juvenile idiopathic ar-
thritis (JIA), childhood-onset systemic lupus erythematosus (C-SLE) and juvenile dermatomy-
ositis (JDM). Gingivitis was more frequently observed in these diseases compared to health 
controls, whereas periodontitis was a rare finding. In JIA patients, gingivitis and periodontitis 
were related to mechanical factors, chronic arthritis with functional disability, dysregulation 
of the immunoinflammatory response, diet and drugs, mainly corticosteroids and cyclospo-
rine. In C-SLE, gingivitis was associated with longer disease period, high doses of corticoste-
roids, B-cell hyperactivation and immunoglobulin G elevation. There are scarce data on peri-
odontal diseases in JDM population, and a unique gingival pattern, characterized by gingival 
erythema, capillary dilation and bush-loop formation, was observed in active patients. In 
conclusion, gingivitis was the most common periodontal disease in PRD. The observed asso-
ciation with disease activity reinforces the need for future studies to determine if resolution 
of this complication will influence disease course or severity.
© 2014 Sociedade Brasileira de Reumatologia. Published by Elsevier Editora Ltda. 
All rights reserved.






Lúpus eritematoso sistêmico juvenil
Dermatomiosite juvenil
r e s u m o
Gengivite e periodontite são doenças periodontais imunoinflamatórias caracterizadas por 
infecções localizadas crônicas geralmente associadas a uma inflamação insidiosa. Essa re-
visão narrativa discute doenças periodontais e mecanismos que influenciam a resposta 
imune e a autoimunidade na área das doenças reumáticas pediátricas (DRP), particular-
mente a artrite idiopática juvenil (AIJ), lúpus eritematoso sistêmico juvenil (LESJ) e der-
matomiosite juvenil (DMJ). Foi notada maior frequência de gengivite nessas doenças em 
comparação com controles sadios, enquanto casos de periodontite foram achados raros. 
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Em pacientes com AIJ, a gengivite e a periodontite estavam relacionadas a fatores mecâni-
cos, artrite crônica com incapacitação funcional, desregulação da resposta imunoinflama-
tória, dieta e medicamentos, principalmente corticosteroides e ciclosporina. Em pacientes 
com LESJ, a gengivite estava associada a períodos mais longos da doença, doses elevadas 
de corticosteroides, hiperativação dos linfócitos B e elevação da imunoglobulina G. São es-
cassos os dados sobre doenças periodontais na população com DMJ; nos pacientes ativos, 
foi observado um padrão gengival singular, caracterizado por eritema gengival, dilatação 
dos capilares e formação arbustiforme. Em conclusão, gengivite foi a doença periodontal 
mais comum em pacientes com DRP. A associação observada com a atividade da doença 
reforça a necessidade de futuros estudos, com o intuito de determinar se a resolução dessa 
complicação irá influenciar o curso ou a gravidade da doença.
© 2014 Sociedade Brasileira de Reumatologia. Publicado por Elsevier Editora Ltda. 
Todos os direitos reservados.
Introduction
Gingivitis and periodontitis are immunoinflammatory peri-
odontal diseases characterized by chronic localized infections 
usually associated with insidious inflammation.1
Periodontal diseases (PD) can cause systemic inflamma-
tion, and it was demonstrated to be an essential underlying 
component of several inflammatory and immune mediated 
diseases, such as atherosclerosis,2 diabetes mellitus3 and sys-
temic autoimmune rheumatic diseases.4 In adults with rheu-
matoid arthritis (RA), PD was associated with disease activity 
and severity5 with a striking similarity between both diseases 
with regard to genetic susceptibility and pathogenesis.6
PD is also relevant for pediatric rheumatic diseases (PRD), 
since poor oral health is a risk factor for systemic infection 
and inflammation in general population and may be more 
important in patients with immune dysregulation under im-
munosuppressive drugs.7 
Therefore, we performed a narrative review and we con-
ducted a series of literature searches in the MEDLINE/PubMed 
database for English language articles focusing on PD in pa-
tients with PRD. The search strategy included a combina-
tion of medical subject headings and keywords. The search 
terms that we used were “periodontal disease”, “gingivitis”, 
“pediatric rheumatic diseases”, “juvenile idiopathic arthritis”, 
“juvenile rheumatoid arthritis”, “juvenile systemic lupus ery-
thematosus”, “childhood-onset systemic lupus erythemato-
sus” and “juvenile dermatomyositis”. The search covered the 
period between 1970 and 2012, and included clinical studies, 
systematic reviews and animal studies. All articles identified 
were full-text papers. 
Periodontal diseases in children and adolescents
Plaque-induced PD has been classified into three subtypes: 
healthy (absence of plaque induced PD), gingivitis (pres-
ence of gingival inflammation without loss of connective 
tissue attachment) and periodontitis (presence of gingival 
inflammation with loss of connective tissue and alveolar 
bone).8 Gingivitis is an inflammatory response to bacteria 
of the dental biofilm, without loss of dental attachment, 
and its prevalence among schoolchildren ranged from 40% 
to 100%.9-12 Periodontitis is a widespread infection affecting 
the tooth support of 10%-15% of the general population.13 
The incidence of periodontitis in pediatric population is 
generally 1%.14 
Children and adolescents can develop PD as a con-
sequence of a local or a systemic factor. Local factors in-
clude: plaque, calculus, orthodontic appliances and dental 
anomalies (such as: enamel projections, enamel pearls). 
Systemic factors include: malnutrition, gender, race, hor-
mones, smoking, systemic diseases and immunosuppres-
sive drugs.15-17 
The more common form of PD in pediatric population 
is gingivitis. This gingival abnormality is characterized 
by a local inflammatory response to microbial challenge 
without bone resorption. However, it is crucial to note that 
young subjects with overt gingival inflammation more fre-
quently exhibit periodontal attachment loss than adoles-
cents without gingival inflammation and gingivitis always 
appears to precede the development of periodontitis.2,15
Most cases of periodontitis described in children and 
adolescents occur as manifestation of systemic diseases, 
such as Papillon-Lefevre syndrome, hypophosphatasia 
and leukocyte adhesion deficiency. These diseases induce 
an impaired immune system, that compromise microbial 
plaque response and increase the likelihood of periodontal 
bone loss and premature teeth loss associated with severe 
and generalized periodontitis during or immediately after 
eruption of the primary teeth.15-17
Pathogenesis of PD
The tooth is an organ with peculiar characteristics in the or-
ganism. It is a hard structure that has one portion immersed 
in connective tissue and another part is exposed to the exter-
nal environment, susceptible to bacterial colonization (Fig. 
1). In addition, bacteria or their products continually interact 
with gingival epithelium to stimulate a host response.18 An 
inflammatory infiltrate (mainly comprised of neutrophils or 
polymorphonuclear leukocytes) is usually present, even in 
the absence of clinically obvious inflammation in order to 
maintain periodontal homeostasis.19
The bacteria associated with PD comprise a group of 
Gram-negative anaerobic organisms, among which the so-
called “red complex” pathogens, especially Porphyromonas 
gingivalis, Treponema denticola and Tannerella forsythia, are 
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more prominent. The reasons for the host response fails to 
control periodontal infection or to inhibit disease progres-
sion are not well understood, but the disruption of host 
homeostasis by periodontal pathogens may be a major con-
tributory factor.20
Gingivitis pathogenesis is characterized initially by a 
vascular response with increased fl uid and infl ammatory 
cell infi ltration in gingiva with perivascular lymphocytic in-
fi ltrate and macrophage cells deposition. Lymphocytes are 
predominantly T cells with a CD4:CD8 ratio of approximately 
2:1.19 Clinical signs of oral infl ammation including bleeding, 
swelling and redness of the gingiva may occur in these pa-
tients.
The persistence of this infl ammatory response results 
in chronic gingivitis with collagen degradation but without 
any dental attachment loss. Gingivitis may progress to peri-
odontitis, but this only occurs in 10% to 15% of the popula-
tion and may be associated with environmental factors and/
or genetic susceptibility.19 The immunological mechanism 
underlying periodontal development involves a shift to a B-
cell/plasma-cell response with high levels of interleukin-1 
(IL-1) and interleukin-6 (IL-6) production, increased chemo-
kine production by macrophages [IL-1b, tumor necrosis fac-
tor-alpha (TNF-Į) and IL-17]21,22 and a consequent enhanced 
osteoclastogenesis with connective tissue destruction and 
alveolar bone loss.22
Cytokines may also modulate the action, differentiation, 
and survival of cells outside the immune system. In this re-
gard, nervous system cells expressing neurotransmitters re-
lated to neurogenic infl ammation23 are known to allow neu-
roplastic changes that are observed in chronic pain. In fact, 
severe periodontal disease was reported by our group to be 
related to refractory craniofacial pain.24
PD and systemic diseases
Regarding periodontal pathogens, the dental plaque is a com-
plex biofi lm with a relevant role in the pathogenesis of PD and 
can serve as a reservoir of microbes with local and systemic 
consequence.25 The systemic exposure to periodontal patho-
gens, their toxins, and periodontal derived/elicited infl am-
matory mediators may have a deleterious effect in different 
organ or systems. Three mechanisms by which periodontal 
infection may infl uence systemic health have been described: 
metastatic infection (caused by translocation of Gram-nega-
tive bacteria from the periodontal pocket to the bloodstream), 
metastatic injury (such as vascular lesions from the effects 
of circulating microbial toxins and pro-infl ammatory media-
tors) and metastatic infl ammation (due to the immunological 
response to the periodontal pathogens and their toxins).25
Indeed, pathogen manipulation may perturb otherwise 
homeostatic host-bacterial interactions, thereby leading to 
non-protective and non-resolving chronic infl ammation.26 
This condition can cause systemic infl ammation that has 
been recognized as an essential component of different mul-
tifactorial diseases, including chronic infl ammatory rheumat-
ic diseases.27
Gingivitis and periodontitis may also induce a variety of 
immunological alterations with circulating immune com-
plexes due to the failure of autoimmune regulation and tol-
erance, contributing the onset and progression of systemic 
autoimmune and rheumatic diseases.4
Periodontal diseases in pediatric rheumatic diseases 
Reports of PD in PRD are restricted to juvenile idiopathic ar-
thritis, childhood-onset systemic lupus erythematosus and 
juvenile dermatomyositis.
Tables 1 and 2 include clinical studies of periodontal dis-
eases in pediatric rheumatic diseases.
Juvenile idiopathic arthritis (JIA)
There is a negative impact on oral health in JIA patients due 
to mechanical factors, chronic arthritis with functional dis-
ability, dysregulation of the immunoinfl ammatory response, 
diet and medications.28-30
Several studies,29-34 reporting that JIA could be a risk factor 
for gingivitis or periodontitis and these pediatric conditions 
were included in the current system classifi cation of PD.8 In 
this regard, chronic arthritis with upper limb disability and re-
duced mandibular mobility due to temporomadibular joint in-
volvement was reported to be an important contributing factor 
for PD in our JIA patients.32 Furthermore, a signifi cant increased 
level of poor oral hygiene in patients with JIA was found.35 On 
the other hand, one study showed that if cofactors (such as: 
age, gender and smoking) are included, the microbial plaque 
(and not the JIA diagnosis) is related to periodontitis.36 
It has been suggested that the association between JIA 
and periodontal disease might be caused by a common dys-
regulation of the immunoinfl ammatory response.37 Increased 
values of IL-10, and TNF-Į in unstimulated blood-cell culture 
Fig. 1 – Periodontal tissues anatomy. (A) Clinical 
examination of healthy gingiva; (B) Periodontal tissues; (C) 
Histological characteristics of gingival
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and IL-1Ra in stimulated blood-cell culture were observed in 
generalized periodontitis, JIA and RA, indicating that these 
cytokines are shared by these diseases.38 In the same way, 
patients with generalized periodontitis may present elevated 
levels of traditional markers of inflammation, such as neutro-
phils, leukocytes, CRP and ESR, similar to observed in patients 
with JIA and RA.39 
Moreover, allele variation of IL-1 gene cluster modify the 
cytokine profiles of patients with aggressive periodontitis as 
JIA, suggesting that this group shared genetic background for 
cytokines profiles.40 
In fact, the increased serum levels of IL-18 and IL-1ȕ in JIA 
patients accompanied by a similar subgingival microbiota 
suggest that the increased frequency of incipient attachment 
loss observed in these patients might be due to their altered 
systemic inflammatory response, making them more suscep-
tible to PD.33 
Additionally, for periodontitis,41 as well as for JIA,42 asso-
ciations to HLA classes I and II alleles were reported, and 
HLA-DRB3 could be a common putative risk for JIA and 
chronic periodontitis among females.43 In fact, the immune 
response to bacteria is influenced by human leucocyte anti-
Table 1 – Clinical studies of periodontal diseases in juvenile idiopathic arthritis
Diseases Country Number of patients and 
healthy controls
Clinical and immunological findings
Walton et al., 200028 UK Review Negative impact of poor oral health 
Miranda et al., 200337 Brazil 32 JIA patients and 24 controls JIA adolescents presented more periodontal attachment 
loss than healthy controls
Welbury et al., 200335 UK 149 JIA patients and 149 controls Increased level of poor oral hygiene and dental decay in 
JIA
Savioli et al., 200432 Brazil 26 JIA patients and 13 controls Gingivitis in JIA patients associated with upper limb 
disability 
Ahmed et al., 200431 UK 55 patients and 55 controls Gingivitis score was significantly higher in JIA compared 
to controls
Miranda et al., 200555 Brazil 38 JIA patients and 29 controls Increased serum IL-18 and IL-1ȕ in JIA patients increased 
susceptibility to PD
Havemose-Poulsen et al., 200538 Denmark 10 JIA, 23 RA, 45 aggressive 
periodontitis patients and 25 
controls
Peripheral blood cytokine profile and citokine secretion 
pattern were showed in by JIA, RA and generalized 
aggressive periodontitis
Miranda et al., 200633 Brazil 18 JIA adolescents and 14 controls No clinical or laboratory differences in periodontal 
inflammation were found in JIA patients and controls
Havemose-Poulsen et al, 200639 Denmark 10 JIA, 23 RA, 45 aggressive 
periodontitis patients and 25 
controls
Elevated levels of traditional markers of inflammation 
were observed in generalized aggressive periodontitis, 
JIA and RA.
Reichert et al, 200636 Germany 78 JIA patients and 75 controls JIA was not a risk factor for periodontitis
Reichert et al., 200743 Germany 110 JIA patients (50 of them 
generalized aggressive 
periodontitis),102 JIA with chronic 
periodontitis and 102 controls
HLA-DRB3n was common risk indicator for JIA and 
chronic periodontitis in females
Havemose-Poulsen et al, 200740 Denmark 10 JIA, 23 RA, 45 aggressive 
periodontitis patients and 25 
controls
Variation of alleles of the IL-1 gene cluster modified 
the cytokine profiles of patients with aggressive 
periodontitis and chronic arthritis
Synodinos et al, 200829 Ireland Review Caries and periodontal disease related to diet, disease 
activity and similar inflammatory process pattern
Leksel et al, 200834 Sweden 41 JIA patients and 41 controls JIA patients showed worse periodontal condition 
compared to controls
Silva et al, 201248 Brazil 16 JIA patients and 11 controls Lower alveolar bone density in JIA patients
JIA, juvenile idiopathic arthritis; RA, rheumatoid arthritis; PD, periodontal disease; UK, United Kingdom; USA, United States of America.
Table 2 – Clinical studies of periodontal diseases in pediatric rheumatic diseases
Diseases Country Number of patients and 
healthy controls
Clinical and immunological findings
JDM
Ghali et al., 199960 USA 5 JDM patients Gingival telangiectases
Marton et al., 200558 Hungary 34 JDM patients Gingival telangiectases
Savioli et al., 201059 Brazil 26 JDM patients and 22 controls Unique gingival pattern associated with cutaneous disease 
C-SLE
Fernandes et al., 200764 Brazil 48 C-SLE patients and 48 children C-SLE patients had inadequate oral hygiene, gingivitis and 
temporomandibular joint dysfunction
Figueredo et al., 200865 Brazil 16 C-SLE patients and 14 controls Increased elastase activity suggested hyperactivity of neutrophils
JDM, juvenile dermatomyositis; C-SLE, childhood-onset systemic lupus erythematosus; USA, United States of America.
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gen (HLA) polymorphism44,45 and individual peptide binding 
capability of cell surface HLA receptors.46 Furthermore, bac-
terial mimicry between bacteria and certain HLA molecules 
could lead to autoimmune reactions or to mechanisms of 
cross-tolerance.47
Patients with JIA showed also lower alveolar bone den-
sity compared to healthy controls, without correlation with 
rheumatologic and periodontal clinical parameters.48 The 
generalized bone loss in arthritis has been suggested to an 
increase of osteoclastic activity and a reduction in the pro-
cess of bone formation. Reduced physical activity and in-
adequate calcium and vitamin D intake can infl uence this 
reduction in bone mineral density.49,50
Microbial challenge, environmental immune response 
modifi ers and host genetic variation can have local and 
systemic repercussion. These effects will induce changes 
in connective tissue and bone metabolism resulting in the 
clinical features observed in JIA with PD (Fig. 2).
The most important factor associated with PD in JIA is 
medication. In this regard, cyclosporine may result in gin-
gival enlargement, ulceration or bleeding.51,52 Long-term use 
of methotrexate in rats with PD enhanced alveolar bone 
destruction.53 Glucocorticoids may have induced osteoporo-
sis,54 and this therapy may also delay wound healing and in-
creased risk of gingival infection,28 however the effect of this 
medication in alveolar bone is unknown in JIA. Despite the 
immunosuppressive treatment, the majority of JIA patients 
presented mild gingivitis without loss of connective tissue 
attachment, and periodontitis was rarely described.32,37,55 In 
addition, JIA patients under anti-TNF blockage had a higher 
frequency of sites with increased probing depth and a lower 
frequency of sites with bleeding on probing,56 however ex-
perimental studies suggested that these drugs might inhibit 
radiographic progression.57
Juvenile dermatomyositis (JDM)
Periodontal diseases were rarely reported in JDM population, 
and the two most important factors present in these patients 
are: reduction of mandibular mobility and gingival altera-
tions.58,59 
Alterations in the masticatory system have been identifi ed 
in JDM patients, such as: hyposalivation, mucosal alterations, 
mainly in the form of telangiectasia,58-63 and weakness of the 
masticatory muscles.58 The reduction of mandibular mobility, 
particularly mouth opening in active JDM patients reinforces 
the possibility that this fi nding is an additional manifesta-
tion of JDM in the masticatory system and a consequence of 
muscle weakness.59
One relevant aspect evidenced in JDM patients was a 
unique gingival pattern, characterized by gingival erythema, 
capillary dilation and bush-loop formation (similar to periun-
gual capillary changes observed in nailfold capillaroscopy) as-
sociated with cutaneous disease activity. This fi nding report-
ed by our group was distinct from PD, suggesting that gingiva 
is a possible target tissue for JDM.59
Childhood-systemic lupus erythematosus (C-SLE)
PRD were also rarely reported in C-SLE population. One study 
observed that C-SLE patients had an inadequate oral hygiene 
with higher incidence of gingivitis and without periodonti-
tis. The most important risk factors for gingivitis were longer 
disease duration and higher cumulative dose of prednisone.64
In C-SLE patients, active elastase was observed in gingival 
crevicular fl uid (GCF) from infl amed sites, even in the pres-
ence of signifi cantly lower levels of IL-18 and IL-13. In con-
trast, the plasma levels of IL-18 and the erythrocyte sedimen-
tation rate were signifi cantly higher in this group of patients. 
The increased elastase activity suggests neutrophils hyperac-
tivity in C-SLE patients, possibly induced by a priming effect 
caused by the high IL-18 plasma levels.65
Conclusions 
In conclusion, gingivitis was the most common periodontal 
disease in PRD. The underlying mechanism is multifactorial 
and includes mechanical factors, chronic arthritis with func-
tional disability, dysregulation of the immunoinfl ammatory 
response, diet and medications, particularly corticosteroids. 
The observed common association with disease activity in all 
reported diseases reinforces the need for future studies to de-
termine if resolution of this complication could infl uence dis-
ease course or severity. In addition, there are some evidence 
that gingiva may be a target tissue in pediatric autoimmune 
rheumatic disease. 
Take-home messages
The most important periodontal disease observed in pediatric 
rheumatic diseases was gingivitis. 
Periodontitis was rarely reported in pediatric rheumatic 
diseases.
Periodontal diseases in JIA patients are multifactorial re-
lated to mechanical factors, functional disability, dysregula-
Fig. 2 – Similarities between periodontal diseases and 
pediatric rheumatic diseases: Microbial challenge, 
environmental immune response modifi ers and 
genetic factors have critical role in pathogenesis of both 
diseases. The host infl ammation, with production of 
antibodies, polymorphonuclears (PMN), cytokines and 
metalloproteinase, has local and systemic effect and trigger 
changes in connective tissue and bone metabolism with 
remarkable clinical signs of diseases
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tion of the immunoinflammatory response, diet and medica-
tions.
A gingival pattern, characterized by gingival erythema, 
capillary dilation and bush-loop formation associated with 
cutaneous disease activity was observed in JDM.
Gingivitis associated with longer disease period and high 
doses of corticosteroids was observed in C-SLE patients.
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